CN115500432A - Granules for preventing and treating bacterial diseases of livestock and poultry and preparation method thereof - Google Patents

Granules for preventing and treating bacterial diseases of livestock and poultry and preparation method thereof Download PDF

Info

Publication number
CN115500432A
CN115500432A CN202211207529.1A CN202211207529A CN115500432A CN 115500432 A CN115500432 A CN 115500432A CN 202211207529 A CN202211207529 A CN 202211207529A CN 115500432 A CN115500432 A CN 115500432A
Authority
CN
China
Prior art keywords
extract
livestock
high molecular
molecular polymer
bacterial diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211207529.1A
Other languages
Chinese (zh)
Inventor
吴俊伟
曾杨梅
唐鑫
姜波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Bull Animal Pharmaceutical Co ltd
Original Assignee
Chongqing Bull Animal Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Bull Animal Pharmaceutical Co ltd filed Critical Chongqing Bull Animal Pharmaceutical Co ltd
Priority to CN202211207529.1A priority Critical patent/CN115500432A/en
Publication of CN115500432A publication Critical patent/CN115500432A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/70Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75Feeding-stuffs specially adapted for particular animals for birds for poultry
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/163Sugars; Polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the field of feed additives, in particular to granules for preventing and treating bacterial diseases of livestock and poultry and a preparation method thereof. The granules for preventing and treating bacterial diseases of livestock and poultry comprise a component A and a component B, wherein the component A and the mass ratio thereof are as follows: per 1000g of A: 20g to 60g of nicotinamide, 20g to 60g of taurine, 80g to 120120g of astragalus extract, 5g to 15g of myrobalan extract, 5g to 15g of myristica fragrans extract, 5g to 15g of liquorice extract, 30g to 70g of berberine hydrochloride, 350g to 550g of glucose and 1000g of starch; b is a high molecular polymer aqueous solution with the concentration of 0.1-1%, and the dosage is as follows: 220mL to 350mL is added to 1000g of A. The invention prepares the vitamins and the traditional Chinese medicine formula into granules, is applied to feed additives, can improve the immunity of animals, regulate intestinal flora to prevent bacterial diseases, can also promote the ingestion of the animals and increase the weight of slaughtering; when the animal has bacterial diseases, the composition can be combined with antibacterial drugs, so that the dosage of the drugs can be reduced, and the recovery of the animals can be promoted; the contained high molecular polymer has slow release effect and can prolong the effective time.

Description

Granules for preventing and treating bacterial diseases of livestock and poultry and preparation method thereof
Technical Field
The invention relates to the field of feed additives, in particular to granules for preventing and treating bacterial diseases of livestock and poultry and a preparation method thereof.
Background
The disease control is particularly important in the process of breeding livestock and poultry, but in recent years, due to the wide and unreasonable use of antibacterial drugs, the problem of bacterial drug resistance is becoming more serious, and the drug resistance level of bacteria is continuously rising, and the development from single drug resistance to multi-drug resistance is shown, so that a plurality of drugs are ineffective in veterinary clinic use, if the use of the antibacterial drugs can be reduced in the breeding process, the generation of bacterial drug resistance is certainly reduced and delayed, the drug residue is reduced, and more green and healthy animal food is provided for human beings.
The traditional Chinese medicine is inherited for thousands of years in China, and also has the effect on preventing and treating infection. Researches show that a part of traditional Chinese medicines have good bacteriostatic effect when being used singly, and some traditional Chinese medicines have good synergistic effect when being used together with antibacterial medicines although the traditional Chinese medicines have no in-vitro antibacterial activity or low antibacterial activity, so that the antibacterial capability of the antibacterial medicines can be enhanced, and the drug resistance of bacteria can be reduced. In addition, some traditional Chinese medicines have the effects of enhancing the immunity of the organism and preventing diseases.
Vitamins are organic compounds necessary for nutrition and growth of human and animals, and play an important role in metabolism, growth, development and health of organisms.
Therefore, the research on the compound of the traditional Chinese medicine and the vitamins has important significance in the application of the compound in the feed additive for promoting the ingestion and the growth of the livestock and poultry, enhancing the resistance of the livestock and poultry, preventing the bacterial diseases of the livestock and poultry, reducing the use of antibacterial drugs in clinic and reducing the drug residue of animal food.
Disclosure of Invention
In view of the above, the invention aims to provide a compound of traditional Chinese medicines and vitamins, which is applied to a feed additive and used for promoting the ingestion and growth of livestock and poultry, enhancing the immunity of livestock and poultry, preventing bacterial diseases of livestock and poultry, reducing the use of antibacterial drugs and the drug residue of animal food in the livestock and poultry breeding process, and providing more green and healthy animal food for human beings.
In order to achieve the above purpose, the invention provides the following technical scheme:
a granule for preventing and treating bacterial diseases of livestock and poultry comprises A and B, and specifically comprises the following components:
the component A and the mass ratio thereof are as follows:
per 1000g of A: .
Nicotinamide 20g to 60g
Taurine (20 g to 60g)
Radix astragali extract 80g to 120g
5g to 15g of myrobalan extract
5g to 15g of nutmeg extract
5g to 15g of licorice extract
30g to 70g of berberine hydrochloride
350g to 550g of glucose
Starch supplement to 1000g
B is a high molecular polymer aqueous solution with the concentration of 0.1-1%, and the dosage is as follows: 220mL to 350mL is added to 1000g of A.
Preferably, the granule for preventing and treating bacterial diseases of livestock and poultry consists of a part A and a part B, and specifically comprises the following components:
the component A and the mass ratio thereof are as follows:
per 1000g of A:
nicotinamide 15g to 50g
Taurine 18g to 50g
90g to 100g of astragalus extract
Myrobalan extract 8g to 15g
Myristica fragrans extract (8g-12g)
Glycyrrhiza extract (6 g to 13g)
Berberine hydrochloride 40g to 60g
400g to 520g of glucose
Starch supplement to 1000g
B is a high molecular polymer aqueous solution with the concentration of 0.1-1%, and the dosage is as follows: 240mL to 330mL are added to 1000g of A.
Preferably, the granule for preventing and treating bacterial diseases of livestock and poultry consists of a part A and a part B, and specifically comprises the following components:
the component A and the mass ratio thereof are as follows:
per 1000g of A:
nicotinamide 45g
Taurine 45g
Radix astragali extract 95g
12g of myrobalan extract
Myristica fragrans extract 11g
Glycyrrhrizae radix extract 12g
Berberine hydrochloride 55g
480g of glucose
Starch supplement to 1000g
B is 0.8% high molecular polymer water solution, and the dosage is: each 1000g of A was added to 260mL.
Further, the livestock and poultry bacterial diseases comprise diseases caused by one or more of escherichia coli, salmonella, staphylococcus aureus and klebsiella.
Further, the high molecular polymer is water soluble, such as one or more of acacia, tragacanth, sodium alginate, peach gum, carboxymethyl starch, acetate starch, methyl cellulose, sodium carboxymethyl cellulose, hydroxyethyl cellulose, and dextran.
Further, the aqueous solution of the high molecular polymer contains ethanol.
Further, the preparation method of the aqueous solution of the high molecular polymer comprises the following steps: weighing a high molecular polymer, adding 95% ethanol which is 2-6 times the weight of the high molecular polymer, fully stirring to completely disperse the high molecular polymer in the 95% ethanol to obtain a suspension, and adding purified water into the suspension to fix the volume to the concentration of the high molecular polymer to be 0.1-1%.
The invention also discloses a preparation method of the granules for preventing and treating bacterial diseases of livestock and poultry, which comprises the following steps:
(1) Mixing fructus Chebulae extract, semen Myristicae extract, and Glycyrrhrizae radix extract, adding nicotinamide and taurine, mixing, adding radix astragali extract, berberine hydrochloride, glucose, and starch, and mixing;
(2) Putting the mixture prepared in the step (1) into a wet granulation pot, spraying the aqueous solution of the high molecular polymer on the surface of the mixture for a few times, and stirring while spraying until the mixture is completely wetted to obtain a soft material;
(3) Preparing the soft material prepared in the step (2) into granules in a swing granulator;
(4) And (3) transferring the prepared granules to an oven for drying at the drying temperature of 60 ℃, detecting the moisture (the moisture should be 3-6%), grading after the moisture is detected to be qualified, and packaging.
The invention has the beneficial effects that: the invention prepares the vitamins and the traditional Chinese medicine into granules, is applied to feed additives, and takes taurine as a growth promoting factor of bifidobacterium, can optimize the intestinal flora structure and has a protective effect on kidney; nicotinamide is a raw material for synthesizing coenzyme I and coenzyme II, and plays an important role in the metabolism of sugar, fat and protein and the formation of high-energy bonds in biological oxidation; the myrobalan has the effects of relieving diarrhea with astringents and astringing lung to relieve cough, and research shows that the myrobalan has a certain antibacterial effect; nutmeg can be used for treating diarrhea and dysentery, and promoting qi circulation and digestion, and is good for promoting ingestion; the radix astragali extract can improve the activity of immunocyte of organism, and has effects of enhancing immunity, enhancing energy, and relieving fatigue; research shows that the combination of the liquorice, the berberine hydrochloride and the antibacterial drug has a synergistic effect and can increase the activity of the drug-resistant bacteria on the antibacterial drug. The vitamins and the traditional Chinese medicine formula are added into daily ration or drinking water of livestock and poultry, so that the immunity of animal organisms can be improved, the disease resistance can be enhanced, intestinal flora can be adjusted, bacterial diseases can be prevented, meanwhile, the ingestion of the animals can be promoted, and the slaughter weight of the animals can be increased; when the animal has bacterial diseases, the antibacterial composition can be combined with antibacterial drugs for application, so that the use amount of the antibacterial drugs can be reduced, and the animal rehabilitation is promoted; the added water-soluble high molecular polymer can play a role of slow release and prolong the time of the granules in exerting effect on animal organisms.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, preferred embodiments of the present invention will be described in detail below.
Example 1
The granule for preventing and treating bacterial diseases of livestock and poultry comprises a component A and a component B, and specifically comprises the following components:
the component A and the mass ratio thereof are as follows:
per 1000g of A:
nicotinamide 45g
Taurine 45g
Radix astragali extract 95g
12g of myrobalan extract
Myristica fragrans Houtt extract 11g
Glycyrrhiza extract 12g
Berberine hydrochloride 55g
480g of glucose
Starch supplement to 1000g
B is 0.8% high molecular polymer water solution, and the dosage is: each 1000g of A was added to 260mL.
The preparation method of the embodiment comprises the following steps:
the first step is as follows: weighing 2.08g of high molecular polymer, adding 8.32g of 95% ethanol, fully stirring to completely disperse the high molecular polymer in the 95% ethanol to obtain a suspension, and adding purified water into the suspension to make the volume to 260mL for later use.
The second step is that: (1) Mixing fructus Chebulae extract, semen Myristicae extract, and Glycyrrhrizae radix extract, adding nicotinamide and taurine, mixing, adding radix astragali extract, berberine hydrochloride, glucose, and starch, and mixing;
(2) Putting the mixture prepared in the step (1) into a wet granulation pot, spraying the aqueous solution of the high molecular polymer on the surface of the mixture for a few times, and stirring while spraying until the mixture is completely wetted to obtain a soft material;
(3) Putting the soft material prepared in the step (2) into a swinging granulator to prepare granules;
(4) And (3) transferring the prepared granules to an oven for drying at the drying temperature of 60 ℃, detecting the moisture (the moisture should be 3-6%), grading after the moisture is detected to be qualified, and packaging.
Example 2
The granule for preventing and treating bacterial diseases of livestock and poultry comprises a component A and a component B, and specifically comprises the following components:
the component A and the mass ratio thereof are as follows:
per 1000g of A:
nicotinamide 50g
Taurine 50g
Radix astragali extract 90g
10g myrobalan extract
Myristica fragrans Houtt extract 12g
Glycyrrhiza extract 10g
Berberine hydrochloride 60g
Glucose 500g
Starch supplement to 1000g
B is a 1% high molecular polymer aqueous solution, and the dosage is as follows: 300mL of the solution was added per 1000g of A.
The preparation method of the embodiment comprises the following steps:
the first step is as follows: weighing 3g of high molecular polymer, adding 15g of 95% ethanol, fully stirring to completely disperse the high molecular polymer in the 95% ethanol to obtain a suspension, and adding purified water into the suspension to reach a constant volume of 300mL for later use.
The second step is that: (1) Mixing fructus Chebulae extract, semen Myristicae extract, and Glycyrrhrizae radix extract, adding nicotinamide and taurine, mixing, adding radix astragali extract, berberine hydrochloride, glucose, and starch, and mixing;
(2) Putting the mixture prepared in the step (1) into a wet granulation pot, spraying the aqueous solution of the high molecular polymer on the surface of the mixture for a few times, and stirring while spraying until the mixture is completely wetted to obtain a soft material;
(3) Preparing the soft material prepared in the step (2) into granules in a swing granulator;
(4) And (3) transferring the prepared granules to an oven for drying at the drying temperature of 60 ℃, detecting the moisture (the moisture should be 3-6%), grading after the moisture is detected to be qualified, and packaging.
Effect example 1
1. Test animal
In a certain meat duck farm, 600 healthy 1-day-old Gao ducks with the weight of 50g to 60g are randomly selected.
2. Test method
The ducklings are randomly divided into 2 groups of 300 ducklings.
Group A feeds formulated duck feed and clean drinking water.
Group B the granules prepared according to example 1 were mixed and drunk at 3 to 5 days old, 8 to 10 days old, 15 to 17 days old, 21 to 23 days old in a proportion of 1g of water per 1L, and the rest feeding modes were the same as those of group A.
The weight of the ducks is weighed at the age of 30 days, and the fatality rate of the two groups of ducks is recorded.
3. Results and analysis
The test results are shown in the following table
Group of Birth average body weight (g) Average body weight (g) at 30 days of age Average body weight gain (g) Rate of disease death
A 57.63 1108.59 1050.96 5.67%
B 55.21 1246.87 1191.66 1.67%
From the test results, the addition of the granules prepared according to example 1 to drinking water can promote the growth of ducks, improve the weight of ducks and obviously reduce the fatality rate of ducks.
Effect example 2
1. Test animal
360 healthy 5-day-old black foot partridge chickens are selected from a certain chicken farm and are fed for 1 week and then grouped.
2. Test method
(1) Grouping: the chicks are randomly divided into 4 groups, namely, a group A, a group B, a group C and a group D, wherein the group A is a healthy control group, the group B is a negative control group, the group C is a positive control group, the group D is a test group, and 90 chicks are respectively arranged in each group.
(2) Molding method
The bacteria for molding are salmonella standard strain CVCC (B) 50335 which are purchased from the inspection institute of veterinary drugs in China.
Preparing bacterial liquid: inoculating the strain into common nutrient broth culture medium, performing shake culture at 37 deg.C for 18-24 h to obtain bacterial liquid, and diluting with sterile MH broth to 3 × 10 8 cfu/ml of bacterial liquid.
Molding: chick pectoralis muscle injection 3X 10 8 0.5ml of cfu/ml salmonella liquid is observed for the clinical symptoms of the chicken every 1 h.
And (3) judging standard of successful molding: when the chickens are in full flock and have the symptoms of listlessness, head weakness and low drooping, blindness, diet reduction or even abolition, loose and disorderly feathers, white and thin feces discharge, excrement paste around the anus and the like, the molding success is indicated. After the model is successfully made, the medicine treatment is carried out.
The B, C and D groups were molded as described above, and the A group was injected with an equal amount of physiological saline.
(3) Feeding and administration method
Group A is a healthy control group, and is fed with formula chicken feed and clean drinking water.
Group B is negative control group, and is fed with formula chicken feed and clean drinking water.
And C group is a positive control group, and is fed with formula chicken feed, and the medicinal drinking water is administered according to the proportion of adding 0.75mL10% enrofloxacin solution into 1L water for 5 days continuously.
Group D was the test group, and the group was fed with a formula chicken feed, and medicated drinking water was administered for 5 days in a proportion of 0.375mL10% enrofloxacin solution and 0.25g of the granule prepared in example 2 per 1L of water.
Mortality was recorded on day 5 of dosing and day 7 of withdrawal.
3. Results recording and analysis
After the chicken is injected with the salmonella bacteria liquid for 2 hours, the chicken shows symptoms of listlessness, head weakness and low drop, blindness and poor standing, diet reduction and even abominability, loose and disorderly feathers and white and thin excrement discharge, which indicates that the molding is successful, and then the chicken is treated according to the administration method. The number of dead chickens on the 5 th day (17 days old) and 7 th day (24 days old) after drug administration is recorded, and the death rate and the treatment effective rate of the chickens are calculated.
Mortality = (number of dead chickens in group/initial total number of chickens in group) × 100%
Effective rate = 1-mortality
Mortality and treatment efficacy of the chickens are shown in the following table
Group of Mortality on day 5 of administration (%) Effective rate on day 5 of administration (%) Mortality on day 7 of drug withdrawal (%) Effective rate (%)% on day 7 after stopping taking medicine
A 0.00 - 6.67 -
B 56.67 - 73.33 -
C 16.67 83.33 20.00 80.00
D 16.67 83.33 16.67 83.33
From the test results, the effective rate of the group D is the same as that of the group C on the 5 th day of administration treatment, which shows that after the dosage of the enrofloxacin is halved, the granules can still achieve the treatment effect when the dosage is not halved after being combined with the granules, namely the granules can reduce the dosage of the enrofloxacin after being combined with the enrofloxacin; the mortality of the group C is increased after the medicine is stopped for 7 days, while the mortality of the group D is not increased, which shows that the combination of the granules and the enrofloxacin can last longer for the treatment of animal organisms, namely the granules have certain slow release.
Finally, it is noted that the above-mentioned embodiments illustrate rather than limit the invention, and that, although the invention has been described in detail with reference to the above-mentioned embodiments, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (8)

1. A granule for preventing and treating bacterial diseases of livestock and poultry is characterized in that: the preparation consists of a part A and a part B, and specifically comprises the following components:
the component A and the mass ratio thereof are as follows:
per 1000g of A: .
Nicotinamide 20g to 60g
Taurine (20 g to 60g)
Radix astragali extract 80g to 120g
5g to 15g of myrobalan extract
5g to 15g of myristica fragrans extract
5g to 15g of licorice extract
30g to 70g of berberine hydrochloride
350g to 550g of glucose
Starch supplement to 1000g
B is a high molecular polymer aqueous solution with the concentration of 0.1-1%, and the dosage is as follows: 220mL to 350mL is added to 1000g of A.
2. The granule for preventing and treating bacterial diseases of livestock and poultry according to claim 1, which is characterized in that: the preparation consists of a part A and a part B, and specifically comprises the following components:
the component A and the mass ratio thereof are as follows:
per 1000g of A:
nicotinamide 15g to 50g
Taurine 18g to 50g
90g to 100g of astragalus extract
Myrobalan extract 8g to 15g
Myristica fragrans extract (8g-12g)
Glycyrrhiza extract (6 g to 13g)
Berberine hydrochloride 40g to 60g
400g to 520g of glucose
Starch supplement to 1000g
B is a high molecular polymer aqueous solution with the concentration of 0.1-1%, and the dosage is as follows: 240mL to 330mL are added to 1000g of A.
3. The granule for preventing and treating bacterial diseases of livestock and poultry according to claim 1, which is characterized in that: the preparation consists of a part A and a part B, and specifically comprises the following components:
the component A and the mass ratio thereof are as follows:
per 1000g of A:
nicotinamide 45g
Taurine 45g
Astragalus extract 95g
12g myrobalan extract
Myristica fragrans extract 11g
Glycyrrhiza extract 12g
Berberine hydrochloride 55g
480g of glucose
Starch supplement to 1000g
B is 0.8% high molecular polymer water solution, and the dosage is: each 1000g of A was added to 260mL.
4. The granule for preventing and treating bacterial diseases of livestock and poultry according to claim 1, which is characterized in that: the bacterial diseases of the livestock and poultry comprise diseases caused by one or more of escherichia coli, salmonella, staphylococcus aureus and klebsiella.
5. The granule for preventing and treating bacterial diseases of livestock and poultry according to any one of claims 1 to 3, characterized in that: the high molecular polymer is water soluble, such as acacia, tragacanth, sodium alginate, peach gum, carboxymethyl starch, acetate starch, methyl cellulose, sodium carboxymethyl cellulose, hydroxyethyl cellulose, dextran, etc.
6. The granule for preventing and treating bacterial diseases of livestock and poultry according to any one of claims 1 to 3, which is characterized in that: the aqueous solution of the high molecular polymer contains ethanol.
7. The granule for preventing and treating bacterial diseases of livestock and poultry according to any one of claims 1 to 3, which is characterized in that: the preparation method of the aqueous solution of the high molecular polymer comprises the following steps: weighing a high molecular polymer, adding 95% ethanol with the weight 2-6 times of that of the high molecular polymer, fully stirring to completely disperse the high molecular polymer in the 95% ethanol to obtain a suspension, and adding purified water into the suspension to fix the volume to the concentration of the high molecular polymer of 0.1-1%.
8. The granule for preventing and treating bacterial diseases of livestock and poultry, as claimed in any one of claims 1 to 3, is prepared by the following steps: (1) Mixing fructus Chebulae extract, semen Myristicae extract, and Glycyrrhrizae radix extract, adding nicotinamide and taurine, mixing, adding radix astragali extract, berberine hydrochloride, glucose, and starch, and mixing;
(2) Putting the mixture prepared in the step (1) into a wet granulation pot, spraying the aqueous solution of the high molecular polymer on the surface of the mixture for a few times, and stirring while spraying until the mixture is completely wetted to obtain a soft material;
(3) Preparing the prepared soft material into granules in a swing granulator;
(4) And (3) transferring the prepared granules to an oven for drying at the drying temperature of 60 ℃, detecting the moisture (the moisture should be 3-6%), grading after the moisture is detected to be qualified, and packaging.
CN202211207529.1A 2022-09-30 2022-09-30 Granules for preventing and treating bacterial diseases of livestock and poultry and preparation method thereof Pending CN115500432A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211207529.1A CN115500432A (en) 2022-09-30 2022-09-30 Granules for preventing and treating bacterial diseases of livestock and poultry and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211207529.1A CN115500432A (en) 2022-09-30 2022-09-30 Granules for preventing and treating bacterial diseases of livestock and poultry and preparation method thereof

Publications (1)

Publication Number Publication Date
CN115500432A true CN115500432A (en) 2022-12-23

Family

ID=84508332

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211207529.1A Pending CN115500432A (en) 2022-09-30 2022-09-30 Granules for preventing and treating bacterial diseases of livestock and poultry and preparation method thereof

Country Status (1)

Country Link
CN (1) CN115500432A (en)

Similar Documents

Publication Publication Date Title
CN104171416B (en) A kind of plant extract feed additive of substitute antibiotics
CN104664160B (en) Freshwater fish composite particles preparation with physiological function and preparation method thereof
CN105341363A (en) Novel compound feed additive for livestock
CN103006820A (en) Chinese medicinal composition with functions of clearing heat and drying dampness and preparation method thereof
CN106036075A (en) Green and environment-friendly milk cow feed additive
CN106620668A (en) Compound tilmicosin solid dispersing agent and preparation method thereof
CN102813056A (en) Micro-biological degradation feed
WO2022241968A1 (en) Plant essential oil for prevention and treatment of coccidiosis and use thereof
CN115500432A (en) Granules for preventing and treating bacterial diseases of livestock and poultry and preparation method thereof
CN106666150A (en) Nonreactive health-care agent capable of improving production performance of breeding pigs and preparation method of nonreactive health-care agent
CN107811128B (en) Feed additive capable of adjusting intestinal flora of piglets
CN107789394B (en) Composition for treating livestock and poultry diarrhea
JP2001008636A (en) Feed composition for preventing infectious disease
RU2410108C1 (en) Method to feed probiotic to suckling piglets
CN113244220A (en) Application of potassium dehydroandrographolide succinate in preparation of veterinary drug for treating cow mastitis and potassium dehydroandrographolide succinate veterinary drug
CN104770618B (en) A kind of Chinese herbal feed additive and preparation method thereof, purposes
CN110179758B (en) Crystalline valnemulin hydrochloride soluble powder capable of being administered by drinking water and application thereof
CN113577112B (en) Pharmaceutical composition for preventing and treating avian salmonellosis and preparation method thereof
CN109938181A (en) A kind of raising immunity of organisms compound pig feed and its preparation method
JP3030048B2 (en) Production method of veterinary drug
CN106138184A (en) A kind of poultry compound medicine containing Radix Glycyrrhizae and amoxicillin
CN107494922A (en) It is a kind of to be used to adjust Tiny ecosystem Chinese herbal feed additive of enteron aisle and preparation method thereof
CN102068536B (en) Compound Chinese medicinal particles and application thereof in preparation of medicament for preventing and treating pig digestive tract disease
RU2684331C1 (en) Method for stimulating productivity and hematopoiesis in rabbits at simultaneous improvement of meat
CN110025774B (en) Ointment for preventing and treating newborn piglet diarrhea and production method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication